Latest News

Shpiner examines why physician trust has declined for years and how AI use reflects, not causes, that shift.

Shpiner explains why patients consult AI before a visit and what physicians should do when the tool gets there first.

The FDA-licensed product is room-temperature-stable, rapidly reconstituted, and intended for adult transfusion when other plasma products are unavailable.

Viatris' new once-weekly patch delivers norelgestromin and ethinyl estradiol, with a Pearl Index of 4.14 in the Phase 3 Luminous Study.

As World Hepatitis Day highlights global testing gaps, an expert outlines how primary care can identify at-risk patients sooner.

FDA clearance adds a noninvasive AI-based test for elevated pulmonary capillary wedge pressure to the CorVista System diagnostic platform.

HTX-001, an antisense oligonucleotide targeting WISPER lncRNA, received FDA Fast Track designation as HAYA Therapeutics advances the therapy for nHCM.

This World Hepatitis Day, 3 expert hepatologists discuss bepirovirsen's functional cure data and weigh primary care against specialized centers for delivering this treatment.